Hosted on MSN

What happens when you metal detect underwater with crocodiles and a python?

We ventured into dangerous waters for some underwater metal detecting, but what we didn’t expect was to be surrounded by crocodiles and a massive python. This video takes you into the wild, where we ...
IEEE

Mask-Supervised Dual-Branch Detection Network for Oriented SAR Ship Detection

Abstract: Oriented ship detection in synthetic aperture radar (SAR) images is widely used for maritime surveillance. However, existing methods suffer from two issues: 1) the feature enhancement ...
Morningstar

DARZALEX FASPRO®-based quadruplet regimen approved in the U.S. for newly diagnosed patients with multiple myeloma who are transplant ineligible

Quadruplet regimen demonstrated significantly deeper and more durable responses, higher MRD negativity and improved progression-free survival versus a standard of care Approval marks the twelfth ...
BioSpace

TECVAYLI® monotherapy demonstrates superior progression-free and overall survival versus standard of care as early as first relapse in patients with multiple myeloma ...

Multiple myeloma is a blood cancer characterized by high rates of relapse. Despite recent advances in treatment, a significant unmet need remains for additional, well–tolerated therapies—particularly ...
Seeking Alpha

TECVAYLI® monotherapy demonstrates superior progression-free and overall survival versus standard of care as early as first relapse in patients with multiple myeloma ...

MajesTEC-9 is the second positive Phase 3 study to support TECVAYLI ® regimens as a potential new standard of care as early as first relapse RARITAN, N.J., Jan. 14, 2026 /PRNewswire/ -- Johnson & ...
GitHub

Dinomaly: The Less Is More Philosophy in Multi-Class Unsupervised Anomaly Detection

Abstract Recent studies highlighted a practical setting of unsupervised anomaly detection (UAD) that builds a unified model for multi-class images. Despite various advancements addressing this ...
Seeking Alpha

DARZALEX FASPRO® is the first and only treatment approved by the U.S. FDA for patients with high-risk smoldering multiple myeloma

Phase 3 AQUILA study showed DARZALEX FASPRO ® significantly reduced the risk of progression to active multiple myeloma or death by 51 percent compared to active monitoring Landmark approval supports ...
Nasdaq

DARZALEX FASPRO® is the first and only treatment approved by the U.S. FDA for patients with high-risk smoldering multiple myeloma

HORSHAM, Pa., Nov. 6, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE:JNJ) today announced the U.S. Food and Drug Administration (FDA) approved DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) as a ...